Status:
TERMINATED
Mindfulness and Cognition in Schizophrenia
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Collaborating Sponsors:
Fondation de l'Avenir
Conditions:
Schizophrenia
Eligibility:
MALE
18-55 years
Phase:
NA
Brief Summary
Mindfulness (innovative and integrative practice in care) allows the individual to adapt his/her behavior (physical and emotional), in a stressful environment, by regulating cardiac activity, especial...
Eligibility Criteria
Inclusion
- DSM-IV diagnosis of schizophrenia (men only)
- aged 18-55
- with no change in antipsychotic medication and clinical status within four weeks prior to the study
- affiliates or entitled to a social security scheme
- who have given their informed consent before participating in the study.
Exclusion
- History of head trauma, neurological disease or not stabilized serious physical illness
- Disorders related to the use of a psychoactive substance, as defined by the DSM-IV (abuse, dependence or withdrawal) within 6 months
- Beta blocking and anti-arrhythmic medications.
Key Trial Info
Start Date :
September 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 12 2021
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT03318640
Start Date
September 11 2018
End Date
July 12 2021
Last Update
December 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Saint Etienne
Saint-Etienne, France, 42055